Ovid Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Ovid Therapeutics

14/05/2024 15:24

* Ovid Therapeutics Inc  OVID.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -19 cents.  The mean expectation of ten analysts
for the quarter was for a loss of 22 cents per share. Wall
Street expected results to range from -26 cents to -17 cents per
share.
    * Revenue rose 123.7% to $148.00 thousand from a year ago;
analysts expected $59.57 thousand. 
    * Ovid Therapeutics Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The company reported a quarterly loss of $11.69 million.
    * Ovid Therapeutics Inc shares had fallen by 1.0% this
quarter and
lost 6.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ovid Therapeutics
Inc is $8.00 
This summary was machine generated from LSEG data May 14 at
02:24 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.22          -0.17          Beat
 Dec. 31 2023      -0.05          -0.22          Missed
 Sep. 30 2023      -0.19          -0.16          Beat
 Jun. 30 2023      -0.20          -0.18          Beat